Nasal Sprays

DRUG10 trials

Sponsors

TERADA Seishi, University of Electronic Science and Technology of China, Center for Genetic Engineering and Biotechnology (CIGB), Center for Genetic Engineering and Biotechnology (CIGB), in Havana, Center for Technological Applications and Nuclear Development (CEADEN)

Conditions

Acute Respiratory Infection (ARI) COVID-19 SARS-CoV2Alzheimer disease dementia dementiaCOVID-19 COVID-19 SARS-CoV2COVID-19 COVID-19 SARS-CoV2COVID-19 Convalescence COVID-19 SARS-CoV2Chronic Hepatitis B Virus infectionHealthyPharmacodynamics and safety in healthy volunteers pharmacodynamics

Phase 1

Effects of Oxytocin Dose Frequency on Behavioral and Neural Responses

University of Electronic Science and Technology of ChinaHealthy

Start: 2018-03-01End: 2018-12-01Target: 150Updated: 2018-10-29

Pharmacodynamics of the Nasalferon in healthy volunteers.

Active, not recruitingRPCEC00000308

Center for Genetic Engineering and Biotechnology (CIGB), in HavanaPharmacodynamics and safety in healthy volunteers pharmacodynamics

Start: 2020-05-04Target: 30Updated: 2026-03-30

Phase 2

Active, not recruitingRPCEC00000337

Center for Genetic Engineering and Biotechnology (CIGB), in HavanaProphylaxis of SARS-CoV-2 infection COVID-19 SARS-CoV2

Start: 2020-10-12Target: 80Updated: 2026-03-30

Active, not recruitingRPCEC00000345

Center for Genetic Engineering and Biotechnology (CIGB), in HavanaCOVID-19 COVID-19 SARS-CoV2

Start: 2020-12-07Target: 88Updated: 2026-03-30

CIGB-Mambisa/Abdala in convalescents

Active, not recruitingRPCEC00000382

Center for Genetic Engineering and Biotechnology (CIGB)COVID-19 Convalescence COVID-19 SARS-CoV2

Start: 2021-07-13Target: 120Updated: 2026-03-30

Phase 3

Active, not recruitingRPCEC00000353

Center for Genetic Engineering and Biotechnology (CIGB), in HavanaCOVID-19 COVID-19 SARS-CoV2

Start: 2021-04-01Target: 354Updated: 2026-03-30

Phase 4

HeberNasvac® Phase IV in Chronic Hepatitis B

Active, not recruitingRPCEC00000283

Center for Genetic Engineering and Biotechnology (CIGB)Chronic Hepatitis B Virus infection

Start: 2018-08-06Target: 300Updated: 2026-03-30

Unknown Phase

Examination of safety of oxytocin for patients with Alzheimer's disease dementia.

Active, not recruitingJPRN-jRCTs061200039

TERADA SeishiAlzheimer disease dementia dementia

Start: 2020-12-25Target: 10Updated: 2025-07-18

Curmeric- Nasal-Safety-Efficacy- Community-Quarantine -COVID-19

Active, not recruitingRPCEC00000352

Center for Technological Applications and Nuclear Development (CEADEN)COVID-19 COVID-19 SARS-CoV2

Start: 2020-10-21Target: 148Updated: 2026-03-30

CIGB2020- ARI elderly contacts

Active, not recruitingRPCEC00000356

Center for Genetic Engineering and Biotechnology (CIGB)Acute Respiratory Infection (ARI) COVID-19 SARS-CoV2

Start: 2021-03-12Target: 1440Updated: 2026-03-30

Related Papers

Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial

Vaccines2024-09-012 citations